 insulin-sulfonylurea therapi treatment niddm past year interest combin insulin sulfonylurea search effect treatment non-insulin-depend diabet niddm patient oral hypoglycem agent sever studi benefici effect therapi niddm patient averag effect small half patient sever problem previou studi small sampl size select patient simultan use sever end point first residu beta-cel function prerequisit benefici effect combin therapi studi improv glycem control sulfonylurea therapi patient insulin-depend diabet mellitu inclus patient impair beta-cel function effect combin therapi second studi glycem control end point nevertheless insulin dose hypoglycemia sulfonylurea comparison treatment insulin dose sulfonylurea insulin dose sulfonylurea patient like combin therapi obes niddm short period beta-cel function patient insulin-sulfonylurea therapi basal insulin secret effect suppress hepat glucos product plasma glucos side effect frequent mild hypoglycem reaction